News

Higher Dose Naloxone Nasal Spray Gets FDA Approval

By

Brian Park, PharmD

Publish Date May 6, 2021

Kloxxado is intended for immediate administration as emergency therapy in settings where opioids may be present.

Combination Treatment Appears Beneficial for Chronic Migraine

By

Cassandra Pardini, PharmD

Publish Date May 6, 2021

Data analysis revealed that CGRP mAbs were discontinued more frequently than onabotulinumtoxinA (23% vs 3%).

Strategies for Managing Uncertainty in Patient Care

By

David Alfandre, MD, MSPH

Publish Date May 6, 2021

For many health care professionals, successfully managing uncertainty means recognizing that surety is complicated and illusory and knowledge is iterative and provisional rather than definitive.

ACR Updates COVID-19 Vaccine Guidance for Managing Patients With Rheumatic and Musculoskeletal Diseases

By

Meghna Rao

Publish Date May 6, 2021

The American College of Rheumatology updated COVID-19 vaccine clinical guidance to include recommendations regarding medication timing considerations during the management of patients with rheumatic and musculoskeletal diseases.

Pfizer and Moderna Vaccines Effective Against New NYC Variant​

Publish Date May 6, 2021

The Pfizer-BioNTech and Moderna COVID-19 vaccines protect against serious illness and death from the coronavirus variant first identified in New York City.

Severe Maternal Morbidity Increased With COVID-19 in Pregnancy

Publish Date May 6, 2021

COVID-19 in pregnancy is associated with increased severe maternal morbidity and mortality.

European Union Will Allow Fully Vaccinated US Tourists This Summer

Publish Date May 6, 2021

American tourists who are fully vaccinated against COVID-19 will be allowed to visit the European Union over the summer.

CDC Reports Millions of Americans Have Missed Second COVID-19 Vaccine Dose

Publish Date May 6, 2021

More than 5 million Americans have missed the second dose of their COVID-19 vaccine.

COVID-19: Reductions in New Opioid Prescription Rates and Buprenorphine Access Go Hand In Hand

By

Lauren Biscaldi

Publish Date May 5, 2021

The researchers’ objective was to study changes in prescriptions for opioid analgesics and buprenorphine for opioid use disorder among both new and existing patients during the COVID-19 pandemic.

Buprenorphine Prescriptions Rose During the Beginning of the Pandemic

By

Heather R. Johnson

Publish Date May 5, 2021

Opioid overdose deaths increased during the pandemic, possibly due to less access to care. The study researchers examined how the pandemic affected patients already prescribed opioids as well as new patients.